| Health / Medical Topics |
Recombinant Fowlpox-Prostate Specific Antigen
A recombinant cancer vaccine consisting of a fowlpox virus vector encoding the prostate-specific antigen (PSA). This agent stimulates cytotoxic T-lymphocytes to target PSA-expressing tumor cells. The fowlpox virus vector is easily manipulated and does not multiply in human tissues. (NCI Thesaurus)
YOU MAY ALSO LIKE
A vaccine consisting of a replication-defective recombinant fowlpox virus that encodes for the murine melanoma antigen glycoprotein 100 (mgp100) with potential antineoplastic…
A viral vaccine comprised of a recombinant fowlpox vector construct encoding a modified epitope of the melanoma antigen glycoprotein 100 (gp100), ES-2092M(gp100),…
A vaccine adjuvant comprised of a recombinant fowlpox virus vector encoding the protein cytokine GM-CSF. GM-CSF is a protein cytokine secreted by…
A cancer vaccine comprised of a recombinant fowlpox virus vector encoding the carcinoembryonic antigen (CEA) and a TRIad of COstimulatory Molecules (B7-1,…
A cancer vaccine made with a form of a chicken virus that does not cause disease in humans. It is being studied…
A cancer vaccine comprised of a recombinant fowlpox virus vector encoding the stimulatory molecule transgene B7-1. Recombinant fowlpox-B7.1 vaccine may enhance antigen…
